High IL-6 levels in COVID-19 patients have been considered as the most objective demonstration of the ongoing “cytokine storm”, as it has been observed in patients with septic shock, cardiac surgery or those receiving treatment with chimeric antigen receptor–transduced T cells (CAR-T) against acute leukemia [15–17]. Here, IL6 is linked to COVID-19.